BNB Plus completes record LineaDNA order as strategic review puts LineaRx in sharper focus
BNB Plus completed a record $1.2 million LineaDNA order for LineaRx. Read what it means for scale, margins, strategy, and BNBX stock sentiment.
Medical Devices & Diagnostics